Annual Cash & Cash Equivalents
$276.40 M
-$180.26 M-39.47%
31 December 2023
Summary:
Integra LifeSciences Holdings annual cash & cash equivalents is currently $276.40 million, with the most recent change of -$180.26 million (-39.47%) on 31 December 2023. During the last 3 years, it has fallen by -$193.76 million (-41.21%). IART annual cash & cash equivalents is now -46.17% below its all-time high of $513.45 million, reached on 31 December 2021.IART Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$215.16 M
-$79.00 K-0.04%
30 September 2024
Summary:
Integra LifeSciences Holdings quarterly cash and cash equivalents is currently $215.16 million, with the most recent change of -$79.00 thousand (-0.04%) on 30 September 2024. Over the past year, it has dropped by -$58.58 million (-21.40%). IART quarterly cash and cash equivalents is now -63.65% below its all-time high of $591.91 million, reached on 31 March 2024.IART Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IART Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.5% | -21.4% |
| 3 y3 years | -41.2% | -54.2% |
| 5 y5 years | +99.1% | +3.5% |
IART Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -46.2% | at low | -63.6% | at low |
| 5 y | 5 years | -46.2% | +99.1% | -63.6% | +8.2% |
| alltime | all time | -46.2% | >+9999.0% | -63.6% | >+9999.0% |
Integra LifeSciences Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $215.16 M(-0.0%) |
| June 2024 | - | $215.24 M(-63.6%) |
| Mar 2024 | - | $591.91 M(+114.1%) |
| Dec 2023 | $276.40 M(-39.5%) | $276.40 M(+1.0%) |
| Sept 2023 | - | $273.73 M(-11.5%) |
| June 2023 | - | $309.19 M(+0.6%) |
| Mar 2023 | - | $307.37 M(-32.7%) |
| Dec 2022 | $456.66 M(-11.1%) | $456.66 M(-10.8%) |
| Sept 2022 | - | $511.94 M(+14.5%) |
| June 2022 | - | $447.15 M(+9.8%) |
| Mar 2022 | - | $407.09 M(-20.7%) |
| Dec 2021 | $513.45 M(+9.2%) | $513.45 M(+9.2%) |
| Sept 2021 | - | $470.23 M(+18.3%) |
| June 2021 | - | $397.41 M(-2.8%) |
| Mar 2021 | - | $408.98 M(-13.0%) |
| Dec 2020 | $470.17 M(+136.4%) | $470.17 M(+18.6%) |
| Sept 2020 | - | $396.28 M(+9.8%) |
| June 2020 | - | $360.98 M(+0.9%) |
| Mar 2020 | - | $357.71 M(+79.8%) |
| Dec 2019 | $198.91 M(+43.3%) | $198.91 M(-4.4%) |
| Sept 2019 | - | $207.98 M(+18.1%) |
| June 2019 | - | $176.08 M(+12.1%) |
| Mar 2019 | - | $157.03 M(+13.1%) |
| Dec 2018 | $138.84 M(-20.6%) | $138.84 M(-32.6%) |
| Sept 2018 | - | $205.99 M(+12.1%) |
| June 2018 | - | $183.77 M(-3.0%) |
| Mar 2018 | - | $189.40 M(+8.3%) |
| Dec 2017 | $174.94 M(+71.4%) | $174.94 M(-63.7%) |
| Sept 2017 | - | $481.94 M(+211.7%) |
| June 2017 | - | $154.60 M(+24.6%) |
| Mar 2017 | - | $124.11 M(+21.6%) |
| Dec 2016 | $102.06 M(+112.0%) | $102.06 M(-5.2%) |
| Sept 2016 | - | $107.60 M(+24.0%) |
| June 2016 | - | $86.80 M(+12.6%) |
| Mar 2016 | - | $77.09 M(+60.2%) |
| Dec 2015 | $48.13 M(-32.9%) | $48.13 M(-39.3%) |
| Sept 2015 | - | $79.31 M(-39.6%) |
| June 2015 | - | $131.30 M(+64.4%) |
| Mar 2015 | - | $79.87 M(+11.3%) |
| Dec 2014 | $71.73 M(-40.5%) | $71.73 M(-48.8%) |
| Sept 2014 | - | $140.23 M(+2.2%) |
| June 2014 | - | $137.16 M(+6.3%) |
| Mar 2014 | - | $129.04 M(+7.0%) |
| Dec 2013 | $120.61 M(+24.4%) | $120.61 M(+1.5%) |
| Sept 2013 | - | $118.87 M(+20.5%) |
| June 2013 | - | $98.64 M(+10.0%) |
| Mar 2013 | - | $89.69 M(-7.5%) |
| Dec 2012 | $96.94 M(-3.8%) | $96.94 M(-22.9%) |
| Sept 2012 | - | $125.72 M(+66.6%) |
| June 2012 | - | $75.47 M(+28.7%) |
| Mar 2012 | - | $58.64 M(-41.8%) |
| Dec 2011 | $100.81 M(-21.7%) | $100.81 M(-9.2%) |
| Sept 2011 | - | $110.99 M(-19.1%) |
| June 2011 | - | $137.28 M(+31.6%) |
| Mar 2011 | - | $104.35 M(-19.0%) |
| Dec 2010 | $128.76 M | $128.76 M(+55.5%) |
| Sept 2010 | - | $82.83 M(-11.5%) |
| June 2010 | - | $93.62 M(+14.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $81.67 M(+13.6%) |
| Dec 2009 | $71.89 M(-60.8%) | $71.89 M(-32.7%) |
| Sept 2009 | - | $106.75 M(-23.0%) |
| June 2009 | - | $138.72 M(-25.3%) |
| Mar 2009 | - | $185.63 M(+1.1%) |
| Dec 2008 | $183.55 M(+220.1%) | $183.55 M(+67.9%) |
| Sept 2008 | - | $109.34 M(+41.4%) |
| June 2008 | - | $77.34 M(-61.1%) |
| Mar 2008 | - | $199.01 M(+247.1%) |
| Dec 2007 | $57.34 M(+152.6%) | $57.34 M(-55.7%) |
| Sept 2007 | - | $129.50 M(+7.2%) |
| June 2007 | - | $120.84 M(+312.0%) |
| Mar 2007 | - | $29.33 M(+29.2%) |
| Dec 2006 | $22.70 M(-51.6%) | $22.70 M(-6.7%) |
| Sept 2006 | - | $24.32 M(-11.7%) |
| June 2006 | - | $27.53 M(+23.0%) |
| Mar 2006 | - | $22.39 M(-52.2%) |
| Dec 2005 | $46.89 M(-32.9%) | $46.89 M(+25.5%) |
| Sept 2005 | - | $37.35 M(+28.7%) |
| June 2005 | - | $29.02 M(-11.4%) |
| Mar 2005 | - | $32.76 M(-53.1%) |
| Dec 2004 | $69.86 M(-11.6%) | $69.86 M(+100.1%) |
| Sept 2004 | - | $34.91 M(-17.9%) |
| June 2004 | - | $42.54 M(-44.1%) |
| Mar 2004 | - | $76.05 M(-3.7%) |
| Dec 2003 | $78.98 M(+81.2%) | $78.98 M(-5.9%) |
| Sept 2003 | - | $83.95 M(-27.7%) |
| June 2003 | - | $116.15 M(+10.5%) |
| Mar 2003 | - | $105.09 M(+141.1%) |
| Dec 2002 | $43.58 M(-2.1%) | $43.58 M(-13.1%) |
| Sept 2002 | - | $50.14 M(-2.1%) |
| June 2002 | - | $51.20 M(+9.5%) |
| Mar 2002 | - | $46.76 M(+5.0%) |
| Dec 2001 | $44.52 M(+216.0%) | $44.52 M(-25.0%) |
| Sept 2001 | - | $59.33 M(+589.8%) |
| June 2001 | - | $8.60 M(-44.1%) |
| Mar 2001 | - | $15.39 M(+9.3%) |
| Dec 2000 | $14.09 M(-27.0%) | $14.09 M(+8.3%) |
| Sept 2000 | - | $13.01 M(+129.2%) |
| June 2000 | - | $5.68 M(-75.7%) |
| Mar 2000 | - | $23.37 M(+21.1%) |
| Dec 1999 | $19.30 M(+264.2%) | $19.30 M(+49.6%) |
| Sept 1999 | - | $12.90 M(+7.5%) |
| June 1999 | - | $12.00 M(+57.9%) |
| Mar 1999 | - | $7.60 M(+43.4%) |
| Dec 1998 | $5.30 M(+152.4%) | $5.30 M(+103.8%) |
| Sept 1998 | - | $2.60 M(-44.7%) |
| June 1998 | - | $4.70 M(-20.3%) |
| Mar 1998 | - | $5.90 M(+181.0%) |
| Dec 1997 | $2.10 M(-82.2%) | $2.10 M(-74.4%) |
| Sept 1997 | - | $8.20 M(+90.7%) |
| June 1997 | - | $4.30 M(-51.1%) |
| Mar 1997 | - | $8.80 M(-25.4%) |
| Dec 1996 | $11.80 M(+162.2%) | $11.80 M(+47.5%) |
| Sept 1996 | - | $8.00 M(-17.5%) |
| June 1996 | - | $9.70 M(-19.2%) |
| Mar 1996 | - | $12.00 M(+166.7%) |
| Dec 1995 | $4.50 M | $4.50 M(-37.5%) |
| Sept 1995 | - | $7.20 M |
FAQ
- What is Integra LifeSciences Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings annual cash & cash equivalents year-on-year change?
- What is Integra LifeSciences Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Integra LifeSciences Holdings?
- What is Integra LifeSciences Holdings quarterly cash and cash equivalents year-on-year change?
What is Integra LifeSciences Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of IART is $276.40 M
What is the all time high annual cash & cash equivalents for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high annual cash & cash equivalents is $513.45 M
What is Integra LifeSciences Holdings annual cash & cash equivalents year-on-year change?
Over the past year, IART annual cash & cash equivalents has changed by -$180.26 M (-39.47%)
What is Integra LifeSciences Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of IART is $215.16 M
What is the all time high quarterly cash and cash equivalents for Integra LifeSciences Holdings?
Integra LifeSciences Holdings all-time high quarterly cash and cash equivalents is $591.91 M
What is Integra LifeSciences Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, IART quarterly cash and cash equivalents has changed by -$58.58 M (-21.40%)